Experimental Gut-Targeted treatment shows promise for easing Autism-Related irritability
NCT ID NCT04895215
Summary
This completed Phase 2 trial tested whether an investigational oral medication called AB-2004 could safely reduce severe irritability in adolescents and adults with autism spectrum disorder (ASD). The study involved 156 participants who took either AB-2004 or a placebo for 8 weeks. Researchers measured changes in irritability and overall severity to see if the treatment was effective and well-tolerated.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AUTISM SPECTRUM DISORDER (ASD are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Baber Research
Naperville, Illinois, 60563, United States
-
Brain Mind Centre
Sydney, New South Wales, 2050, Australia
-
CNS Solutions
Jacksonville, Florida, 32256, United States
-
CNS Solutions
Orlando, Florida, 32801, United States
-
Children's Health Queensland Hospital
South Brisbane, Queensland, 4101, Australia
-
Clinical Research of Southern Nevada
Las Vegas, Nevada, 89128, United States
-
Cortica Marin
San Rafael, California, 94903, United States
-
Cortica Westlake
Westlake Village, California, 91361, United States
-
Harmonex Neuroscience Research
Dothan, Alabama, 36303, United States
-
IMMUNOe Research Centers
Centennial, Colorado, 80112, United States
-
Monash Kids Research
Clayton, Victoria, 3186, Australia
-
Murdoch Children's Research Institute
Parkville, Victoria, 3052, Australia
-
Nathan S. Kline Institute for Psychiatric Research
Orangeburg, New York, 10962, United States
-
Ohio State University
Columbus, Ohio, 43210, United States
-
Optimal Clinical Trials
Grafton, Auckland, 1010, New Zealand
-
Relaro Medical Trials
Dallas, Texas, 75243, United States
-
Southwestern Autism Research and Resource Center
Phoenix, Arizona, 85006, United States
-
Spectrum Neuroscience and Treatment Institute
New York, New York, 10021, United States
-
University of Arizona
Tucson, Arizona, 85724, United States
-
University of Missouri, Thompson Center for Autism and Neurodevelopmental Disorders
Columbia, Missouri, 65201, United States
-
University of South Florida
Tampa, Florida, 33613, United States
-
Vanderbilt University Medical Center
Nashville, Tennessee, 37212, United States
-
Westmead Children's Hospital
Sydney, New South Wales, 2145, Australia
-
Yale University
New Haven, Connecticut, 06519, United States
Conditions
Explore the condition pages connected to this study.